// STATE LEGISLATION TRACKER

Florida HB 1333: Testing of Cosmetics on Animals

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Florida
Bill: HB 1333
Session: 2026
Filed: 2026-01-09
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

HB1333 was about banning cosmetics animal testing and restricting the sale of cosmetics tested on animals. Based on the title, summary, subjects, and status, it does not affect compounded peptides, prescribing, telehealth, clinician scope, FDA 503A/503B compounding, controlled substances, or PDMP rules.

Key Points

No apparent effect on peptide prescribing or access
No change to compounding pharmacies or 503A/503B rules
No change to NP, naturopathic, or telehealth practice
No controlled-substance or prescription-monitoring impact

What to Watch For

Note The bill died in committee, so it is not active law for Florida peptide users or clinicians.

Note If refiled, it appears focused on cosmetics manufacturing, not medical peptides or prescriptions.

Where the Bill Stands

The bill died in the House Industries & Professional Activities Subcommittee on March 13, 2026.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws